Benzinga | Feb 18, 2021 11:33AM EST

JP Morgan Maintains Overweight on 10x Genomics, Raises Price Target to $195

JP Morgan analyst Tycho Peterson maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $160 to $195.